Clinical trial
Endoscopic Relapse Risk Factors After Ileocolic Resection on Crohn's Disease Patients in the Biologic Era
NCT06299631 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endoscopic Relapse Risk Factors After Ileocolic Resection on Crohn's Disease Patients in the Biologic Era
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- December 31, 2023
- Enrollment
- 133 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease